El Mundo on MSN2d
US approves a new painkiller with less risk of addiction than opioids and equally potentThe suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...
A new study by the Substance Abuse and Mental Health Services Administration, a branch of the US Department of Health and ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
FOX News on MSN12d
FDA approves opioid-free pain medication with 'no sign of addiction'A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
Columbus Ledger-Enquirer (Ga.) on MSN11d
FDA approves a new pain med that could eliminate addiction. When can GA patients get it?The combined cost of opioid use disorder and fatal overdose in Georgia is ... but this is yet unproven. It is not without ...
Time on MSN11d
FDA Approves the First Non-Opioid Pain Drug in 20 YearsThe prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Washington Examiner on MSN13d
FDA approves first new class of painkiller in 20 years, a non-addictive opioid alternativeThe medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
As an orthopedic and sports medicine surgeon and chairman at Inova Sports Medicine, Dr. Robin West is no stranger to sports-related injuries. She understands that developing an effective game plan to ...
A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...
Journavx can be taken with ibuprofen for its anti-inflammatory effects. The prescription medication is not in pharmacies yet, but it maybe there by the end of February. Click here to report a typo.
Professor Dame Ijeoma Uchegbu discusses the nanoparticle delivery system behind the non-addictive pain medication Envelta and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results